Bulletin
Investor Alert

New York Markets Open in:

Sept. 23, 2022, 8:43 a.m. EDT

Keyword: Endexx Corporation (US: EDXC) Sees Future In International Expan-sion And Positioning As Non-Nicotine Vaping From Its Hyla Subsidiary's Guarana-Based Product Has Company Planning For Placement In19 Countries By End Of 2022

new
Watchlist Relevance
LEARN MORE

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

  • X
    ENDEXX Corp. (EDXC)

or Cancel Already have a watchlist? Log In

/zigman2/quotes/208751111/delayed EDXC +1.55%

Sep 23, 2022 (Stock Market Press via COMTEX) -- Endexx Corporation (OTC: EDXC) sees its future in international expansion and positioning in the Non-Nicotine Vaping brand from its Hyla subsidiary's Guarana-based product. The Company is planning for placement in up to19 countries by the end of 2022, Nick Mehdi, Hyla CEO, says. The Company has initiated marketing approvals in eight new countries -- including Germany, Israel and Italy. The takeover of Hyla meshes with the EDXC existing strategy of marketing a complete and natural wellness line of skincare products.

StockMarketPress is a media company which is spotlighting the cannabis industry analyzing how growth in cannabis legalization by state in 2022 could impact companies and investors. Some of the stocks it recently reported on include Endexx Corporation (OTC: EDXC) Aurora Cannabis Inc. (NYSE:ACB) (TSX: ACB), Supreme Cannabis Co. (OTC: SPRWF), The Green Organic Dutchman (TSX: TGOD) (OTCQX: TGODF), OrganiGram Holdings Inc. (NASDAQ: OGI), Canopy Growth Corp. (NASDAQ: CGC) CBD Unlimited, Inc. (OTC PINK: EDXC).

The new countries where marketing approvals have been initiated include: Germany, Italy, Israel, Egypt, Slovenia, Romania, Iran and Bahrain. These eight new country markets if approved will be added to Hyla's currently active markets including the US, Canada, Czech Republic, Georgia, Russia, Slovakia, South Africa, Switzerland, United Arab Emirates, the U.K., and Uzbekistan, the company says.

In addition to the Hyla brand of non-nicotine vaping, EDXC also markets a complete line of skincare products including balms, creams, lotions, butters, masks, scrubs and oils. The goal is healthy skin and grooming wellness. Formulations have ingredients designed for optimal absorption and support of skin health.

This dovetails with the Company's acquisition and marketing of safe, non-nicotine plant based vaping utilizing the Guarana plant.

Nick Mehdi, Hyla CEO, commented, "With more than 1,000 stores carrying the (Hyla vaping product) in the U.S., and the potential to expand our market penetration to as many as 19 countries by the end of 2022, we are excited to add our product line to the already strong retail presence Endexx maintains."

EDXC believes its acquisition on controlling interest in Hyla will expand its international distribution and mean a "significant increase in the company's consolidated revenue. Endexx further states that the Hyla proprietary device produces an unprecedented number of 4,500 puffs per device. Its initial inventory of 140,000 devices were sold out within the initial months of its availability, Endexx says. It also says the device is CE approved and has UL global safety certification.

The Company added, "The Hyla acquisition continues to be an important milestone for Endexx as it not only has provided additional revenue -- which we expect to experience immediately -- and new international distribution for both our CBD Unlimited and Blesswell

(TM)
product lines, but it also significantly clears the overhang from our balance sheet. This consolidation and simplification of our debt structure will enable us to fund our operations more easily, and create future growth, unencumbered by complex and potentially toxic debt."

EDXC also says the acquisition 'significantly improves' its balance sheet by removing overhang through reduction of promissory obligations and cancellation of warrants. For additional information on the acquisition, please see Endexx's recent Form 8-K filing.

Source: Stock Market Press

Join Stock Market Press' newsletter for the latest in IPO, market commentary and company profiles.

Stock Market Press is a financial news company that delivers up to date stock news, introduces private and public companies to a wide audience of investors, consumers, journalists and the general public via social media and a rapidly expanding network.

Contact:

Stock Market Press
110 Wall St.
New York, NY 10005 info@stockmarketpress.com https://twitter.com/PressStock

Safe Harbor Statement:

Statements in this news release may be "forward-looking statements." Forward-looking statements include, but are not limited to, statements that express our intentions, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions. These statements are based on current expectations, estimates and projections about our business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and are likely to, differ materially from what is expressed or forecasted in forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date of this news release and Stock Market Press undertakes no obligation to update any forward-looking statement to reflect events or circumstances after the date of this news release.

See Stock Market Press disclaimer: http://stockmarketpress.com/disclaimer/ SOURCE: Stock Market Press

COMTEX_415124784/2617/2022-09-23T08:42:53

Is there a problem with this press release? Contact the source provider Comtex at editorial@comtex.com. You can also contact MarketWatch Customer Service via our Customer Center.

/zigman2/quotes/208751111/delayed
US : U.S.: OTC
$ 0.06
+0.0009 +1.55%
Volume: 13,320
Nov. 25, 2022 12:58p
P/E Ratio
N/A
Dividend Yield
N/A
Market Cap
$30.81 million
Rev. per Employee
$118,185
loading...

This Story has 0 Comments
Be the first to comment

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.